Navigation Links
Zimmer Holdings to Present at Upcoming Investor Conferences
Date:9/1/2009

WARSAW, Ind., Sept. 1 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today it will be participating in the following investor conferences during the month of September:

  • Thomas Weisel Partners Healthcare Conference 2009 in Boston, Mass., on September 9, 2009, at 11:30 a.m. Eastern Time;
  • Morgan Stanley Healthcare Unplugged 2009 Conference in New York, N.Y., on September 14, 2009, at 8:35 a.m. Eastern Time; and
  • UBS Global Life Sciences Conference in New York, N.Y., on September 21, 2009, at 8:00 a.m. Eastern Time.

Live webcasts of the presentations can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcasts will be archived for replay following the conferences.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmerman Travels Across Country for $10M Weight Loss
2. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
4. Zimmer Holdings to Present at Deutsche Bank 34th Annual Health Care Conference
5. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2009 Results
7. Zimmer Announces Expiration of Deferred Prosecution Agreement
8. Zimmer Holdings Names Marc Casper to Board of Directors
9. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
10. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
11. Zimmer Reports Fourth Quarter and 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... Guide ...      , No matter on which side of the Atlantic devicemakers do ... device regulations they have to follow. , In addition to the full text of ...
(Date:6/28/2017)... ... , ... Anyone with a remote control has seen the never-ending twists on the house flipping ... get rich in no time. But what about the buyers of the flipper's flip. ... of a flipped house. An email recently sent to Gary Case said, “Just closed ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... ... , ... American Farmer proudly announces the participation of Pure Line Seeds, Inc ... to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... seed. As demand grew, the small company located in Moscow, Idaho extended its sales ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: